T. Rowe Price Associates’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42K Hold
10,425
﹤0.01% 3016
2025
Q1
$37K Hold
10,425
﹤0.01% 2958
2024
Q4
$69K Buy
+10,425
New +$69K ﹤0.01% 2882